Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease
- 1 October 2015
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 82, 466-477
Abstract
No abstract availableKeywords
Funding Information
- The Cure Huntington's Disease Initiative (CHDI) (A-5303)
- National Institute of Health (NS030687, NS064114, HL96571, HL098351, DA08259)
This publication has 60 references indexed in Scilit:
- Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s DiseasePLOS ONE, 2013
- Imbalance of p75NTR/TrkB protein expression in Huntington’s disease: implication for neuroprotective therapiesCell Death & Disease, 2013
- Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosisNature Neuroscience, 2013
- Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's DiseasePLOS ONE, 2012
- Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175PLOS ONE, 2012
- Neuronal Growth Cone Retraction Relies on Proneurotrophin Receptor Signaling Through RacScience Signaling, 2011
- Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's DiseasePLOS ONE, 2011
- Neuronal release of proBDNFNature Neuroscience, 2009
- Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patientsHuman Molecular Genetics, 2008
- Brain‐derived neurotrophic factor over‐expression in the forebrain ameliorates Huntington’s disease phenotypes in miceJournal of Neurochemistry, 2007